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Introduction
Medullary thyroid carcinoma (MTC) is a relatively 
uncommon malignancy arising from parafollicular 
C-cells that accounts for 3.5-10% of thyroid cancers 
(Melvin et al., 1968; McCook et al., 1982). MTC may 
be more aggressive than well-differentiated thyroid 
cancer (papillary, follicular) because it has a greater 
propensity to present with regional or distant metastasis 
at the time of initial diagnosis (Lairmore et al., 1991; 
Bankoff et al., 1987; Jimenez et al., 1995), and 10-year 
survival rates are approximately 40-50% (Gharib et al., 
1992). Therefore, early diagnosis of MTC is important to 
improve long-term prognosis. Among several diagnostic 
tools for MTC, ultrasonography (US) with fine needle 
aspiration (FNA) has most often been adopted, as for other 
well-differentiated thyroid cancers (Frates et al., 2005). 
However, the reported sensitivity of FNA for diagnosing 
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Abstract
 Purpose: To correlate ultrasonographic (US) features of medullary thyroid carcinoma (MTC) with pre-
operative and post-operative calcitonin levels. Materials and Methods: A total of 130 thyroid nodules diagnosed 
as MTC were evaluated. Two radiologists retrospectively evaluated preoperative US features according to size, 
shape, margin, echogenicity, type of calcification, and lymph node status. Postoperative clinical and imaging 
follow-up (mean duration 31.9 ± 22.5 months) was performed for detection of tumor recurrence. US features, 
presence of LN metastasis, and tumor recurrence were compared between MTC nodules with and without elevated 
preoperative calcitonin (>100 pg/mL). Those with normalized and non-normalized postoperative calcitonin 
levels groups were also compared. Results: Common US features of MTCs were solid internal content (90.8%), 
irregular shape (44.6%), circumscribed margin (46.2%), and hypoechogenicity (56.2%). Comparing MTC 
nodules with and without elevated preoperative calcitonin levels, the size and shape of MTC nodule and lymph 
node metastasis showed statistical significance (p<0.05). Postoperative calcitonin normalization correlated with 
US features of tumor size (p=0.002), margin (p=0.034), shape (p≤0.001), and presence of calcification (p=0.046). 
Tumor recurrence and LN metastasis were more prevalent in patients without normalization of postoperative 
calcitonin than in those with normalization (p=0.001). Conclusions: Serum calcitonin measurement is helpful for 
early diagnosis and predicting prognosis. Postoperative calcitonin measurement is also important for postoperative 
US follow up, especially in cases with larger nodule size, presence of calcification, irregular shape, and irregular 
margin. 
Keywords: Medullary thyroid cancer - ultrasonographic features - preoperative calcitonin - postoperative calcitonin
RESEARCH ARTICLE
Ultrasonographic Features of Medullary Thyroid Carcinoma: 
Do they Correlate with Pre- and Post-Operative Calcitonin 
Levels?
Kyung Eun Cho1, Hye Mi Gweon1, Ah Young Park1,2, Mi Ri Yoo1, Jeong-Ah Kim1, 
Ji Hyun Youk1, Young Mi Park2,3, Eun Ju Son1*
MTC is only 56% (Trimboli et al., 2015). 
An important additional diagnostic tool is serum 
calcitonin, a sensitive and specific marker for MTC that 
has been widely used for diagnosis and post-surgical 
follow up (Costante et al., 2007). However, routine use of 
serum calcitonin measurement has been limited because it 
is not cost effective in North America, European centers 
and guidelines recommend calcitonin screening in nodular 
thyroid disease (Kloos et al., 2009; Gharib et al., 2010). 
Although several studies have recently documented 
characteristic US features of MTC (Saller et al., 2002; Kim 
et al., 2009; Fukushima et al., 2009; Lee et al., 2010; Choi 
et al., 2011), they focused on comparisons with papillary 
thyroid cancer (Kim et al., 2009; Lee et al., 2010) or with 
benign nodules (Saller et al., 2002). To our knowledge, 
no reports correlating US features of MTC with serum 
calcitonin level have been published to date.
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Materials and Methods
Patient selection
The institutional review board approved this 
retrospective study and the need for informed consent 
was waived. From November 2007 through October 
2010, 188 patients were diagnosed with MTC after 
total thyroidectomy. We excluded 67 patients without 
preoperative sonography images and 5 patients without 
preoperative or postoperative calcitonin levels. Four 
patients were also excluded because they have already 
underwent total thyroidectomy at the time of US imaging. 
The final study group consisted of 112 patients (80 women 
and 32 men; age range 21-81) with 130 MTCs: a single 
MTC nodule in 94 patients and bilateral MTC nodules 
in 18 patients. Mostly, total thyroidectomy with central 
node dissection was done except nineteen patients (total 
thyroidectomy with modified radical neck dissection).
Image analysis 
US and FNA were performed as a baseline study before 
surgery. Six radiologists with 5-15 years of experience 
performed real-time US with a commercially available 
7-12-MHz linear transducer (iU22 scanners, Philips 
Healthcare). Retrospective review of the sonographic 
images was performed in consensus by two radiologists 
with 5 and 15 years of experience who were blinded to 
the pathologic results. They analyzed US features of 
thyroid nodules according to internal components (solid or 
mixed), echogenicity (isoechoic, hypoechoic, or markedly 
hypoechoic), margins (circumscribed, microlobulated, 
or irregular), calcifications (microcalcification or 
macrocalcification), shape (oval, round [taller than wide], 
or irregular), and final assessment of the nodules. The size 
of nodules was recorded according to previous sonography 
reports. We also reviewed preoperative US images for 
the presence of lymph node metastasis. Postoperative US 
imaging follow up (mean duration 31.89 ± 22.51 months) 
was performed for detection of tumor recurrence.
Malignant features were defined on the basis of 
previously published criteria as marked hypoechogenicity, 
microlobulated or irregular margins, microcalcifications, 
and taller than wide shape (Kim et al., 2002).
When a thyroid nodule showed one or more of the 
malignant features described previously, it was assessed 
as suspicious for malignancy. When a thyroid nodule 
showed none of the malignant or indeterminate features, 
it was assessed as probably benign. When a thyroid 
nodule showed one or more indeterminate feature and no 
malignant features, regardless of the presence of benign 
features, it was assessed as low suspicion of malignancy.
Serum calcitonin levels
The majority of patients had values for serum calcitonin 
measured using chemiluminescent immumoassay (ARUP, 
UT; Simens Immulite 2000; reference range, <5 pg/mL 
for women, <8.4 pg/mL for men). The highest calcitonin 
level in the preoperative period and the lowest calcitonin 
level in postoperative period were recorded. According 
to ATA guidelines, elevated preoperative calcitonin was 
defined as > 100 pg/ml (Kloos et al., 2009).
Postoperative follow-up and evaluation of recurrence 
in our department were as follows. We routinely measured 
basal calcitonin levels on the first day and the 7th day after 
surgery. MTC nodules with normalized postoperative 
calcitonin level were classified when basal calcitonin was 
within the normal range and the peak calcitonin level was 
less than threefold greater than basal calcitonin.
Statistical analysis
US features, presence of LN metastasis, and tumor 
recurrence were compared between MTC nodules with 
and without elevated preoperative calcitonin (>100 pg/
mL). MTC nodules with normalized and non-normalized 
postoperative calcitonin levels (normal value, <5 pg/mL 
for women, <8.4 pg/mL for men) were also compared. The 
chi-square test was used for analysis. Statistical analysis of 
differences in size was performed with the Student’s t- test. 
A value of p < 0.05 was considered statistically significant.
Results 
A summary of the results is presented in Tables 
1, 2, and 3. The common US features of MTC were 
solid internal content (90.8%), irregular shape (44.6%), 
circumscribed margin (46.2%), and hypoechogenicity 
(56.2%). The mean size of 130 MTC nodules was 16.22 
± 12.69 mm. Forty-nine nodules (37.7%) were classified 
as suspicious for malignancy, 48 (36.9%) as low suspicion 
for malignancy, and 33 (25.4%) as probably benign.
The study group consisted of 81 MTC nodules 
Figure 1. Medullary Thyroid Carcinomas with (a) 
Elevated Preoperative Calcitonin and Without (b) 
Elevated Preoperative Calcitonin Levels. Both medullary 
thyroid carcinoma nodules show similar ultrasonographic 
features including solid internal content, irregular shape and 
margin, marked hypoechogenicity except size. (a) A 46-year-old 
man shows 28 mm sized nodule whereas, (b) A 48-year-old man 
shows 3 mm sized nodule
Fig 1a Fig 1b 
Figure 2. Medullary Thyroid Carcinomas with 
(a) Postoperative Calcitonin Normalization and 
without (b) Postoperative Calcitonin Normalization. 
(a) A 44-year-old man shows 10 mm sized nodule with 
ultrasonographic features of oval shape, circumscribed margin 
without calcification. (b) A 55-year-old woman shows 32 mm 
sized nodule with ultrasonographic features of irregular shape, 
irregular margin and presence of calcification
Fig 2a Fig 2b 
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associated with elevated preoperative calcitonin and 49 
MTC nodules without elevation of calcitonin. Eighty-two 
MTC nodules showed normalized postoperative calcitonin 
whereas 48 MTC nodules did not show postoperative 
calcitonin normalization (Tables 1, 2). 
The mean size of nodules with elevated preoperative 
calcitonin levels was significantly larger than that of 
nodules without elevated preoperative calcitonin levels 
Table 1. Comparison of Ultrasonographic Features of Medullary Thyroid Carcinoma according to Preoperative 
Calcitonin Level
Ultrasonographic features Preoperative calcitonin level >100 Preoperative calcitonin level P value(n=130) (n=81)  <100 (n=49)
Mean size (mm ± SD) 21.0±12.79 8.31±7.59 <0.001
Diagnosis 0.947
   Probably benign 21 (25.9) 12 (24.5)
   Low suspicion for malignancy 29 (35.8) 19 (38.8)
   Suspicion for malignancy 31 (38.3) 18 (36.7)
Internal content 0.133
   Solid 71 (87.7) 47 (95.9)
   Mixed 10 (12.3) 2 (4.1)
Shape 0.004
   Oval 35 (43.2) 13 (26.5)
   Round 8 (9.9) 16 (32.7)
   Irregular 38 (46.9) 20 (40.8)
Margin 0.056
   Circumscribed 38 (46.9) 22 (44.9)
   Microlobulated 16 (19.8) 3 (6.1)
   Irregular 27 (33.3) 24 (49.0)
Echogenicity 0.358
   Markedly hypoechoic 19 (23.5) 16 (32.7)
   Hypoechoic 46 (56.8) 27 (55.1)
   Isoechoic 16 (19.7) 6 (12.2)
Calcification 0.589
   Absence 40 (49.4) 27 (55.1)
   Presence 41 (50.6) 22 (44.9)
Type of calcification 0.772
   Microcalcification 30 (71.4) 15 (30.6)
   Macrocalcification 11 (28.6) 7 (14.3)
Table 2. Comparison of Ultrasonographic Features of Medullary Thyroid Carcinoma according to Presence or 
Absence of Postoperative Calcitonin Normalization
Ultrasonographic features (n=130) Normalized Postoperative 
Calcitonin (n=82)
Non-normalized Postoperative 
Calcitonin (n=48)
P value
   Mean size (mm ± SD) 13.41±10.76 21.0±14.33 0.002
Diagnosis 0.289
   Probably benign 21 (25.6) 12 (25.0)
   Low suspicion for malignancy 34 (41.5) 14 (29.2)
   Suspicion for malignancy 27 (32.9) 22 (45.8)
Internal content 0.125
   Solid 77 (93.9) 41 (85.4)
   Mixed 5 (6.1) 7 (14.6)
Shape <0.001
   Oval 33 (40.2) 15 (31.3)
   Round 22 (26.8) 2 (4.2)
   Irregular 27 (32.9) 31 (64.6)
Margin 0.034
   Circumscribed 45 (54.9) 15 (31.3)
   Microlobulated 10 (12.2) 9 (18.7)
   Irregular 27 (32.9) 24 (50) 
Echogenicity 0.282
   Markedly hypoechoic 26 (31.7) 9 (18.8)
   Hypoechoic 43 (52.4) 30 (62.4)
   Isoechoic 13 (15.9) 9 (18.8)
Calcification 0.046
   Absence 48 (58.5) 19 (39.6)
   Presence 34 (41.4) 29 (60.4)
Type of calcification 0.58
   Microcalcification 23 (28.0) 22 (45.8)
   Macrocalcification 11 (13.4) 7 (14.6)
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(21.0 ± 12.79 versus 8.31 ± 7.59 mm; p < .001). There was 
a significant difference in shape between MTC nodules 
with and without elevated preoperative calcitonin level 
(p = 0.004). However, there was no statistical difference 
in internal content (p = 0.133), margin (p = 0.056), 
echogenicity (p = 0.358), and presence of calcification (p 
= 0.589) between MTC nodules with and without elevated 
preoperative calcitonin levels (Table 1, Figure 1).
The mean size of nodules without postoperative 
calcitonin normalization was significantly larger than 
the mean size of nodules with postoperative calcitonin 
normalization (21 ± 14.33 versus 13.41 ± 10.76 mm; p 
< 0.002). Comparison of MTC nodules with and without 
postoperative calcitonin normalization showed statistical 
significance for margin (p = 0.034), shape (p <0.001), and 
presence of calcification (p = 0.046). However, there was 
no statistical difference in internal content (p = 0.125) or 
echogenicity (p = 0.282) between MTC nodules with and 
without normalization of postoperative calcitonin (Table 
2, Figure 2).
Lymph node metastasis showed statistical significance 
between MTC nodules with and without elevated 
preoperative calcitonin levels (p < 0.001). Both tumor 
recurrence and LN metastasis were more prevalent in 
patients without normalization of postoperative calcitonin 
than in those with normalization (p = 0.001) (Table 3).
Discussion
Although there have been several studies evaluating 
US findings of MTCs (Kim et al., 2009; Lee et al., 2010; 
Saller et al., 2002; Fukushima et al., 2009; Choi et al., 
2011), our study includes the largest series of US findings 
in primary MTC reported to date from a single center. 
Furthermore, the focus of our study was to evaluate US 
findings according to preoperative and postoperative 
serum calcitonin, which has not been documented in 
previous reports. 
The most common US findings of MTCs in this study 
were solid internal content (90.8%), irregular shape 
(44.6%), circumscribed margin (46.2%), hypoechogenicity 
(56.2%), and absence of calcification (51.5%). Forty-
nine nodules (37.7%) were classified as suspicious for 
malignancy, 48 (36.9%) as low suspicion for malignancy, 
and 33 (25.4%) as probably benign.
In terms of echogenicity and margins in US findings of 
MTC nodules, our study showed similar results to previous 
studies including hypoechoic internal echogenicity and 
circumscribed margin (Gorman et al., 1987; Saller et al., 
2002; Lee et al., 2010; Choi et al., 2011). Among nodules 
with calcification (48.5%), microcalcifications were found 
in 71.4% of the lesions and macrocalcifications in 28.6%. 
A similar pattern of calcification was observed in previous 
studies (Kim et al., 2009; Lee et al., 2010). However, in 
terms of shape, our study showed that MTC nodules were 
more likely to have an irregular shape than an oval or 
round shape, which is different from that reported in other 
studies. In a study by Lee et al.(Lee et al., 2010), round 
to oval shape was present in 67.4% of all MTC nodules 
investigated, whereas irregular and taller than wide shapes 
of MTC nodules were observed in only 19.6% and 13%, 
respectively. Kim et al. and Choi et al. also showed that 
the shape of MTC nodules was more likely to be oval to 
round than irregular or taller than wide (Kim et al., 2009; 
Choi et al., 2011). We found that MTC nodules tended to 
show malignant features rather than benign features, with 
the exception of the circumscribed margin. 
A substantial number of MTC nodules (74.6%) in 
the current study were classified as low suspicion or 
suspicious for malignancy; these results are in agreement 
with previous studies including those of Lee et al. 
(71.7%), Kim et al. (2009) (81%), Choi et al. (72.2%), 
and Fukushima et al. (70.1%) (Kim et al., 2009; Lee 
et al., 2010; Fukushima et al., 2009; Choi et al., 2011). 
Nonetheless, quite a large number of MTC nodules were 
diagnosed as probably benign. In this study, 33 of 130 
MTC nodules (25.4%) lacked US findings typical for 
thyroid carcinoma and were diagnosed as probably benign. 
In other words, based on US findings, at least one out of 
four MTC nodules would not be diagnosed as possibly 
malignant and therefore would not undergo FNAB. This 
might worsen the overall prognosis of MTC patients.
In addition to thyroid US, FNA is another widely 
adopted diagnostic method for thyroid nodules based 
on the assumption that it has an acceptable reliability to 
distinguish between benign and malignant lesions (Kim 
et al., 2002; Frates et al., 2005). According to several 
reports, the accuracy, sensitivity, and specificity of FNA 
was 95%, 83%, and 92%, respectively (Gharib et al., 1994; 
Danese et al., 1998). However, the use of FNA has been 
established for papillary thyroid carcinomas, and Bugalho 
et al. reported the sensitivity of FNA in diagnosing MTCs 
to be only 63% (Melvin et al., 1968). It was similar with 
the result of our institution (66%). Failure to detect typical 
features of MTCs, such as amyloid, in routine methods and 
the presence of cytologic patterns that mimic papillary, 
anaplastic, or follicular carcinoma can cause problems 
(Geddie et al., 1984; Takeichi et al., 1989). If cytologic 
examination does not show the malignant potential of the 
tumor, MTC nodules might be diagnosed as benign and 
Table 3. Correlation between Preoperative and Postoperative Calcitonin Level and Lymph Node Metastasis or 
Tumor Recurrence
LN metastasis Tumor recurrence P valueAbsence Presence Absence Presence
Total (n=130) 87 (66.9) 43 (33.1) 120 (-92.3) 10 (7.7)
Preoperative calcitonin level Elevated (n=81) 44 (54.3) 37 (45.7) 73 (90.1) 8 (9.9) <0.001
Non-elevated (n=49) 43 (87.8) 6 (12.2) 47 (95.9) 2 (4.1) 0.318
Postoperative calcitonin level Normalized (n=82) 70 (85.4) 12 (14.6) 81 (98.8) 1 (1.2) <0.001
Non-normalized (n=48) 17 (35.4) 31 (64.6) 39 (81.3) 9 (18.7) 0.001
LN, lymph node
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might not undergo thyroidectomy. 
Considering the high false-negative rate of FNA 
(Hahm et al., 2001; Trimboli et al., 2015) and US in 
diagnosing MTC, we inevitably need an additional 
diagnostic tool for early and precise diagnosis of MTC. 
The serum calcitonin level has been considered a sensitive 
and specific marker for MTC based on the fact that MTC 
arises from the parafollicular “C” cells and produces 
calcitonin. Although its effectiveness is still controversial 
(Costante et al., 2007) several studies have evaluated 
the utility of serum calcitonin measurement (Hahm et 
al., 2001; Elisei et al., 2004; Cheung et al., 2008). For 
example, Elisei et al. reviewed 10,864 patients and found 
that preoperative serum calcitonin measurement in thyroid 
nodules is the most informative test for early diagnosis 
and overcame the frequent false negative results of FNAB. 
The survival rate was significantly better in MTCs detected 
by serum calcitonin measurement than in MTCs not 
detected by serum calcitonin measurement (Elisei et al., 
2004). In the present work, tumor size and presence of LN 
metastasis correlated with preoperative calcitonin level. 
A similar pattern was also observed in the reports of Yip 
et al. (2011). Likewise, Cohen et al revealed that serum 
calcitonin below a threshold calcitonin level of 100 pg/
mL was associated with a median tumor size of 0.3 cm, 
compared with 2.0 cm for a calcitonin level >100 pg/mL 
(Cohen et al., 2000). 
Preoperative serum calcitonin level helps early 
diagnosis and predicts the prognosis of MTCs whereas 
postoperative serum calcitonin levels indicate the presence 
of persistent or recurrent tumors (Yip et al., 2011). 
We found that postoperative calcitonin normalization 
correlated not only with tumor size but also with tumor 
margin, presence of calcification, and tumor recurrence. 
Therefore, after total thyroidectomy, it is necessary to 
check the postoperative calcitonin level in addition to 
postoperative follow up imaging with US, especially for 
MTC nodules with larger size, presence of calcification, 
and irregular margin. 
There are a few limitations of this study. First, this was a 
retrospective study design and prospective evaluation with 
real-time sonography is therefore needed. Additionally, 
the reviewers were aware of the final diagnosis, which 
might have influenced the results. Second, not all MTCs 
secrete calcitonin; for example, advanced tumors may 
dedifferentiate with a subsequent decrease in calcitonin 
production. Furthermore, hypercalcitoninemia is also 
associated with non-tumorous conditions such as 
autoimmune thyroid disease, hypergastrinemia and C-cell 
hyperplasia; other factors that increase calcitonin are 
alcohol consumption, smoking, sepsis, and heterophilic 
anticalcitonin antibodies (d’Herbomez et al., 2007; 
Kotzmann et al., 1999). Finally, patients in our study 
didn’t undergo pentagastrin stimulating test (Costante et 
al., 2007) or calcitonin measurement in washout of the 
needle after aspiration which may increase diagnostic 
accuracy (Trimboli et al., 2012).
In conclusion, although most MTCs show US 
findings of malignant thyroid nodules, at least one out 
of four MTC nodules appears probably benign on US. 
In addition, MTC shows a high false-negative rate in 
FNA. Therefore, measurement of preoperative serum 
calcitonin is helpful for early diagnosis and predicting 
prognosis before performing thyroidectomy. Postoperative 
calcitonin measurement is also an important supplement 
to postoperative US follow up, especially in cases with 
larger nodule size, presence of calcification, irregular 
shape, and irregular margin.
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